SCHEDULE 13G/A
Statement of Beneficial Ownership
Roivant Sciences Ltd. Filed Acc 0001213900-25-044436
Stakes reported in this filing
Stake history · largest stake in each 13D and 13G
- 2026-11-05 SCHEDULE 13G/A · FMR LLC 11.8%
- 2026-10-27 SCHEDULE 13G/A · BlackRock, Inc. 8.2%
- 2026-10-05 SCHEDULE 13D/A · Roivant Sciences Ltd. 19.5%
- 2026-08-13 SCHEDULE 13G/A · Morgan Stanley 5.7%
- 2026-05-12 SCHEDULE 13G/A · Morgan Stanley 6.9%
- 2026-05-06 SCHEDULE 13G/A · Ramaswamy Vivek 3.6%
- 2026-03-27 SCHEDULE 13G/A · The Vanguard Group 0%
- 2026-03-06 SCHEDULE 13G/A · FMR LLC 10.3%
- 2026-02-17 SCHEDULE 13G/A · SB Investment Advisers (UK) Limited 2.3%
- 2026-02-13 SCHEDULE 13G/A · Ramaswamy Vivek 6.8%
- 2026-02-11 SCHEDULE 13G/A · Morgan Stanley 8.0%
- 2025-12-12 SCHEDULE 13D/A · Roivant Sciences Ltd. 55.9%
- 2025-11-14 SCHEDULE 13G/A · SB Investment Advisers (UK) Limited 5.8%
Loading xslSCHEDULE_13G_X01/primary_doc.xml…